Literature DB >> 32437554

The consequences of altered microbiota in immune-related chronic kidney disease.

Wei Ling Lau1, Yongen Chang1, Nosratola D Vaziri1.   

Abstract

The normal gut microbiome modulates host enterocyte metabolism and shapes local and systemic immunity. Accumulation of urea and other waste products in chronic kidney disease induces gut dysbiosis and intestinal wall inflammation (leaky gut). There are decreased numbers of bacteria that generate short-chain fatty acids, which are an important nutrient source for host enterocytes and also contribute to regulation of the host immune system. Anaerobic proteolytic bacteria that express urease, uricase and indole and p-cresol enzymes, such as Enterobacteria and Enterococci, are increased. Microbial-derived uremic toxins such as indoxyl sulfate and trimethylamine N-oxide contribute to the pathophysiology of immune-related kidney diseases such as diabetic nephropathy, lupus nephritis and immunoglobulin A (IgA) nephropathy. Animal and clinical studies suggest potential benefits of dietary and probiotic interventions in slowing the progression of immune-related kidney diseases.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  IgA nephropathy; chronic kidney disease; diabetic nephropathy; gut microbiome; lupus nephritis

Mesh:

Substances:

Year:  2021        PMID: 32437554      PMCID: PMC8633451          DOI: 10.1093/ndt/gfaa087

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  63 in total

Review 1.  Metformin and gut microbiota: their interactions and their impact on diabetes.

Authors:  Natalia G Vallianou; Theodora Stratigou; Stylianos Tsagarakis
Journal:  Hormones (Athens)       Date:  2019-02-04       Impact factor: 2.885

2.  Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases.

Authors:  N D Vaziri; B Dure-Smith; R Miller; M K Mirahmadi
Journal:  Am J Gastroenterol       Date:  1985-08       Impact factor: 10.864

3.  Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial.

Authors:  Hamid Tayebi Khosroshahi; Nosratola D Vaziri; Behzad Abedi; Bahlol Habibi Asl; Morteza Ghojazadeh; Wanghui Jing; Amir Mansur Vatankhah
Journal:  Hemodial Int       Date:  2018-03-13       Impact factor: 1.812

Review 4.  The Gut as a Source of Inflammation in Chronic Kidney Disease.

Authors:  Wei Ling Lau; Kamyar Kalantar-Zadeh; Nosratola D Vaziri
Journal:  Nephron       Date:  2015-05-09       Impact factor: 2.847

Review 5.  The interaction between smoking, alcohol and the gut microbiome.

Authors:  Gabriele Capurso; Edith Lahner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-10-22       Impact factor: 3.043

6.  Gender bias in autoimmunity is influenced by microbiota.

Authors:  Leonid Yurkovetskiy; Michael Burrows; Aly A Khan; Laura Graham; Pavel Volchkov; Lev Becker; Dionysios Antonopoulos; Yoshinori Umesaki; Alexander V Chervonsky
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

Review 7.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

8.  Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial.

Authors:  Zarin Sadat Ebrahimi; Ensieh Nasli-Esfahani; Azadeh Nadjarzade; Hassan Mozaffari-Khosravi
Journal:  J Diabetes Metab Disord       Date:  2017-06-02

9.  Control of lupus nephritis by changes of gut microbiota.

Authors:  Qinghui Mu; Husen Zhang; Xiaofeng Liao; Kaisen Lin; Hualan Liu; Michael R Edwards; S Ansar Ahmed; Ruoxi Yuan; Liwu Li; Thomas E Cecere; David B Branson; Jay L Kirby; Poorna Goswami; Caroline M Leeth; Kaitlin A Read; Kenneth J Oestreich; Miranda D Vieson; Christopher M Reilly; Xin M Luo
Journal:  Microbiome       Date:  2017-07-11       Impact factor: 14.650

10.  Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study.

Authors:  Johan R Simonsen; Valma Harjutsalo; Asko Järvinen; Juha Kirveskari; Carol Forsblom; Per-Henrik Groop; Markku Lehto
Journal:  BMJ Open Diabetes Res Care       Date:  2015-03-05
View more
  6 in total

Review 1.  Faecal Microbiota Transplantation and Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 2.  Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.

Authors:  Iwona Filipska; Agata Winiarska; Monika Knysak; Tomasz Stompór
Journal:  Toxins (Basel)       Date:  2021-04-10       Impact factor: 4.546

Review 3.  Phosphate, Microbiota and CKD.

Authors:  Chiara Favero; Sol Carriazo; Leticia Cuarental; Raul Fernandez-Prado; Elena Gomá-Garcés; Maria Vanessa Perez-Gomez; Alberto Ortiz; Beatriz Fernandez-Fernandez; Maria Dolores Sanchez-Niño
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

Review 4.  Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin.

Authors:  Susanna Campo; Antonio Lacquaniti; Domenico Trombetta; Antonella Smeriglio; Paolo Monardo
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

5.  The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.

Authors:  Yuwei Wang; Jin Zhao; Yunlong Qin; Zixian Yu; Yumeng Zhang; Xiaoxuan Ning; Shiren Sun
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 6.  Autoimmunity and COVID-19 - The microbiotal connection.

Authors:  Nurit Katz-Agranov; Gisele Zandman-Goddard
Journal:  Autoimmun Rev       Date:  2021-06-10       Impact factor: 17.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.